Mark S. Sands

Mark S. Sands

Washington University in St. Louis

H-index: 64

North America-United States

About Mark S. Sands

Mark S. Sands, With an exceptional h-index of 64 and a recent h-index of 31 (since 2020), a distinguished researcher at Washington University in St. Louis, specializes in the field of lysosomal storage diseases, gene therapy, mouse models, enzyme replacement.

His recent articles reflect a diverse array of research interests and contributions to the field:

GABAergic interneurons contribute to the fatal seizure phenotype of CLN2 disease mice

Haploinsufficiency of lysosomal enzymes and Alzheimer’s disease

Decrease in psychosine in response to a ceramide galactosyltransferase inhibitor in a novel human cell model of Krabbe disease

An innovative gene therapy approach to produce novel GALC variant with enhanced protein stability and enzyme activity with high levels of mannose 6-phosphate for Krabbe disease

Assessing the Co-Chaperone and Synaptic Protein DNAJC5 as a Therapeutic Target in Alzheimer’s Disease (P1-6.010)

Spontaneous seizures associated with cortical interneuron loss in Cln2R207X mice are ameliorated via gene therapy

circRNAs mediate the effect of chronic lysosomal dysfunction on Alzheimer’s disease pathology

Preclinical studies in Krabbe disease: A model for the investigation of novel combination therapies for lysosomal storage diseases

Mark S. Sands Information

University

Position

School of Medicine

Citations(all)

11480

Citations(since 2020)

2969

Cited By

9643

hIndex(all)

64

hIndex(since 2020)

31

i10Index(all)

135

i10Index(since 2020)

81

Email

University Profile Page

Washington University in St. Louis

Google Scholar

View Google Scholar Profile

Mark S. Sands Skills & Research Interests

lysosomal storage diseases

gene therapy

mouse models

enzyme replacement

Top articles of Mark S. Sands

Title

Journal

Author(s)

Publication Date

GABAergic interneurons contribute to the fatal seizure phenotype of CLN2 disease mice

bioRxiv

Keigo Takahashi

Nicholas R Rensing

Elizabeth M Eultgen

Sophie H Wang

Hemanth R Nelvagal

...

2024

Haploinsufficiency of lysosomal enzymes and Alzheimer’s disease

Molecular Genetics and Metabolism

Mark Sands

Bruno Benitez

Clare Wallace

Neal Goodwin

Kevin Odell

...

2024/4/1

Decrease in psychosine in response to a ceramide galactosyltransferase inhibitor in a novel human cell model of Krabbe disease

Molecular Genetics and Metabolism

Rodrigo T Starosta

Steven Q Le

Xiaoxia Cui

Robert E Schmidt

Xuntian Jiang

...

2024/2/1

An innovative gene therapy approach to produce novel GALC variant with enhanced protein stability and enzyme activity with high levels of mannose 6-phosphate for Krabbe disease

Molecular Genetics and Metabolism

Hung Do

Mark Sands

Yicheng Zhao

Andrew Hedman

Jennifer Srnak

...

2024/2/1

Assessing the Co-Chaperone and Synaptic Protein DNAJC5 as a Therapeutic Target in Alzheimer’s Disease (P1-6.010)

Matthew Rosene

Niko Nykänen

Kevin O’Dell

Marie Nunez

Oscar Harari

...

2023/4/25

Spontaneous seizures associated with cortical interneuron loss in Cln2R207X mice are ameliorated via gene therapy

Molecular Genetics and Metabolism

Keigo Takahashi

Elizabeth M Eultgen

Sophie H Wang

Nicholas Rensing

Hemanth R Nelvagal

...

2023/2/1

circRNAs mediate the effect of chronic lysosomal dysfunction on Alzheimer’s disease pathology

Alzheimer's & Dementia

Skarleth Cardenas Romero

Abdallah M Eteleeb

Niko‐Petteri Nykanen

Kevin O’Dell

Marie Nunez

...

2023/12

Preclinical studies in Krabbe disease: A model for the investigation of novel combination therapies for lysosomal storage diseases

Gregory Heller

Allison M Bradbury

Mark S Sands

Ernesto R Bongarzone

2023/1/4

Gene therapy ameliorates spontaneous seizures associated with cortical neuron loss in a Cln2R207X mouse model

The Journal of Clinical Investigation

Keigo Takahashi

Elizabeth M Eultgen

Sophie H Wang

Nicholas R Rensing

Hemanth R Nelvagal

...

2023/6/15

Bowel dysmotility and enteric neuron degeneration in lysosomal storage disease mice is prevented by gene therapy

bioRxiv

Matthew J Jansen

Letitia L Williams

Sophie Wang

Elizabeth M Eultgen

Keigo Takahashi

...

2023

Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes

Nature communications

Jisu Oh

Amy E Riek

Kevin T Bauerle

Adriana Dusso

Kyle P McNerney

...

2023/6/13

A positive feedback loop between chronic lysosomal dysfunction and circRNAs in Alzheimer’s disease mouse models (P5-6.008)

Skarleth Cardenas Romero

Abdallah Etelee

Niko Nikane

Kevin O’Dell

Marie Roberts

...

2023/4/25

Effects of chronic cannabidiol in a mouse model of naturally occurring neuroinflammation, neurodegeneration, and spontaneous seizures

Scientific reports

Joshua T Dearborn

Hemanth R Nelvagal

Nicholas R Rensing

Keigo Takahashi

Stephanie M Hughes

...

2022/7/4

Methods of detecting, preventing, reversing, and treating neurological diseases

2022/1/27

CRISPR-Cas9 Knock-In of T513M and G41S Mutations in the Murine β–Galactosyl-Ceramidase Gene Re-capitulates Early-Onset and Adult-Onset Forms of Krabbe Disease

Frontiers in Molecular Neuroscience

Rima Rebiai

Emily Rue

Steve Zaldua

Duc Nguyen

Giuseppe Scesa

...

2022/5/10

Cortical interneuron loss and seizure generation as novel clinically relevant disease phenotypes in Cln2R207X mice

bioRxiv

Keigo Takahashi

Elizabeth M Eultgen

Sophie H Wang

Nicholas R Rensing

Hemanth R Nelvagal

...

2022/3/13

Efficacy of recombinant human PPT1 enzyme replacement therapy in mouse and sheep models of CLN1 disease

Molecular Genetics and Metabolism

Hemanth R Nelvagal

Samantha L Eaton

Sophie H Wang

Elizabeth M Eultgen

Keigo Takahashi

...

2022/2/1

Cross-species efficacy of enzyme replacement therapy for CLN1 disease in mice and sheep

The Journal of Clinical Investigation

Hemanth R Nelvagal

Samantha L Eaton

Sophie H Wang

Elizabeth M Eultgen

Keigo Takahashi

...

2022/10/17

Amelioration of enteric nervous system defects via gene therapy in CLN1 disease mice

Molecular Genetics and Metabolism

Jonathan D Cooper

Sophie H Wang

Letitia L Williams

Elizabeth M Eultgen

Keigo Takahashi

...

2022/2/1

Biochemical evaluation of intracerebroventricular rhNAGLU-IGF2 enzyme replacement therapy in neonatal mice with Sanfilippo B syndrome

Molecular genetics and metabolism

Shih-hsin Kan

Ibrahim Elsharkawi

Steven Q Le

Heather Prill

Linley Mangini

...

2021/6/1

See List of Professors in Mark S. Sands University(Washington University in St. Louis)